Transcriptional Regulation during CD8 T-Cell Immune Responses

  • Ivana Munitic
  • César Evaristo
  • Hsueh Cheng Sung
  • Benedita Rocha
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 684)


Naïve CD8 T cells differentiate in response to antigen stimulation. They acquire the capacity to express multiple effector molecules and mediate effector functions that contribute to infection control. Once antigen loads are reduced they revert progressively to a less activated status and eventually reach a steady-state referred to as “memory” that is very different from that of naïve cells. Indeed, these “memory” cells are “ready-to-go” populations that acquired the capacity to respond more efficiently to antigen stimulation. They modify their cell cycle machinery in order to divide faster; they likely improve DNA repair and other cell survival mechanisms in order to survive during division and thus to generate much larger clones of effector cells; finally, they also mediate effector functions much faster. 1These modifications are the consequence of changes in the expression of multiple genes i.e., on the utilization of a new transcription program.


Memory Cell Kill Target Cell Transcription Apparatus Tumor Necrosis Factor Alpha Gene NFAT Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rocha B, Tanchot C. The tower of babel of CD8+ T-cell memory: known facts, deserted roads, muddy waters and possible dead ends. Immunol Rev 2006; 211:182–196.PubMedCrossRefGoogle Scholar
  2. 2.
    Kadonaga JT. Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors. Cell 2004; 116:247–257.PubMedCrossRefGoogle Scholar
  3. 3.
    Orphanides G, Reinberg D. A unified theory of gene expression. Cell 2002; 108:439–451.PubMedCrossRefGoogle Scholar
  4. 4.
    Woychik NA, Hampsey M. The RNA polymerase II machinery: structure illuminates function. Cell 2002; 108:453–463.PubMedCrossRefGoogle Scholar
  5. 5.
    Colman-Lerner A, Gordon A, Serra E et al. Regulated cell-to-cell variation in a cell-fate decision system. Nature 2005; 437:699–706.PubMedCrossRefGoogle Scholar
  6. 6.
    Peixoto A, Evaristo C, Munitic I et al. CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response. J Exp Med 2007; 204:1193–1205.PubMedCrossRefGoogle Scholar
  7. 7.
    Blackwood EM, Kadonaga JT. Going the distance: a current view of enhancer action. Science 1998; 281:60–63.PubMedCrossRefGoogle Scholar
  8. 8.
    Wilson CB, Merkenschlager M. Chromatin structure and gene regulation in T-cell development and function. Curr Opin Immunol 2006; 18:143–151.PubMedCrossRefGoogle Scholar
  9. 9.
    Ansel KM, Djuretic I, Tanasa B et al. Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 2006; 24:607–656.PubMedCrossRefGoogle Scholar
  10. 10.
    Fitzpatrick DR, Shirley KM, Kelso A. Cutting edge: stable epigenetic inheritance of regional IFN-gamma promoter demethylation in CD44highCD8+ T-lymphocytes. J Immunol 1999; 162:5053–5057.PubMedGoogle Scholar
  11. 11.
    Zhou W, Chang S, Aune TM. Long-range histone acetylation of the Ifng gene is an essential feature of T-cell differentiation. Proc Natl Acad Sci USA 2004; 101:2440–2445.PubMedCrossRefGoogle Scholar
  12. 12.
    Kersh EN, Fitzpatrick DR, Murali-Krishna K et al. Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T-cells. J Immunol 2006; 176:4083–4093.PubMedGoogle Scholar
  13. 13.
    Northrop JK, Thomas RM, Wells AD et al. Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T-cells is influenced by CD4 T-cells. J Immunol 2006; 177:1062–1069.PubMedGoogle Scholar
  14. 14.
    Chandele A, Joshi NS, Zhu J et al. Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T-cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1. J Immunol 2008; 180:5309–5319.PubMedGoogle Scholar
  15. 15.
    Fann M, Godlove JM, Catalfamo M et al. Histone acetylation is associated with differential gene expression in the rapid and robust memory CD8(+) T-cell response. Blood 108, 3363–3370 (2006).PubMedCrossRefGoogle Scholar
  16. 16.
    Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 2002; 109 (Suppl):S67–79.PubMedCrossRefGoogle Scholar
  17. 17.
    Peng SL, Gerth AJ, Ranger AM et al. NFATc1 and NFATc2 together control both T-and B-cell activation and differentiation. Immunity 2001; 14:13–20.PubMedCrossRefGoogle Scholar
  18. 18.
    Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005; 5:472–484.PubMedCrossRefGoogle Scholar
  19. 19.
    Masuda ES, Imamura R, Amasaki Y et al. Signalling into the T-cell nucleus: NFAT regulation. Cell Signal 1998; 10:599–611.PubMedCrossRefGoogle Scholar
  20. 20.
    Huang GN, Huso DL, Bouyain S et al. NFAT binding and regulation of T-cell activation by the cytoplasmic scaffolding Homer proteins. Science 2008; 319:476–481.PubMedCrossRefGoogle Scholar
  21. 21.
    Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene 2001; 20:2476–2489.PubMedCrossRefGoogle Scholar
  22. 22.
    Hogan PG, Chen L, Nardone J et al. Transcriptional regulation by calcium, calcineurin and NFAT. Genes Dev 2003; 17:2205–2232.PubMedCrossRefGoogle Scholar
  23. 23.
    Barlic J, McDermott DH, Merrell MN et al. Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1-and NFAT2-dependent mechanisms. J Biol Chem 2004; 279:48520–48534.PubMedCrossRefGoogle Scholar
  24. 24.
    Intlekofer AM, Takemoto N, Wherry EJ et al. Effector and memory CD8+ T-cell fate coupled by T-bet and eomesodermin. Nat Immunol 2005; 6:1236–1244.PubMedCrossRefGoogle Scholar
  25. 25.
    Beima KM, Miazgowicz M, Lewis M et al. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J Biol Chem 2006; 281:11992–12000.PubMedCrossRefGoogle Scholar
  26. 26.
    Pearce EL, Mullen AC, Martins GA et al. Control of effector CD8+ T-cell function by the transcription factor Eomesodermin. Science 2003; 302:1041–1043.PubMedCrossRefGoogle Scholar
  27. 27.
    Lewis MD, Miller SA, Miazgowicz MM et al. T-bet’s ability to regulate individual target genes requires the conserved T-box domain to recruit histone methyltransferase activity and a separate family member-specific transactivation domain. Mol Cell Biol 2007; 27:8510–8521.PubMedCrossRefGoogle Scholar
  28. 28.
    Intlekofer AM, Takemoto N, Kao C et al. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T-cells. J Exp Med 2007; 204:2015–2021.PubMedCrossRefGoogle Scholar
  29. 29.
    Sullivan BM, Juedes A, Szabo SJ et al. Antigen-driven effector CD8 T-cell function regulated by T-bet. Proc Natl Acad Sci USA 2003; 100:15818–15823.PubMedCrossRefGoogle Scholar
  30. 30.
    Schoenborn JR, Dorschner MO, Sekimata M et al. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat Immunol 2007; 8:732–742.PubMedCrossRefGoogle Scholar
  31. 31.
    Yu J, Wei M, Boyd Z, Lehmann EB et al. Transcriptional control of human T-BET expression: the role of Sp1. Eur J Immunol 2007; 37:2549–2561.PubMedCrossRefGoogle Scholar
  32. 32.
    Kaczynski J, Cook T, Urrutia R. Sp1-and Kruppel-like transcription factors. Genome Biol 2003; 4:206.PubMedCrossRefGoogle Scholar
  33. 33.
    Hai T, Hartman MG. The molecular biology and nomenclature of the activating transcription factor/ cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001; 273:1–11.PubMedCrossRefGoogle Scholar
  34. 34.
    Woolf E, Xiao C, Fainaru O et al. Runx3 and Runx1 are required for CD8 T-cell development during thymopoiesis. Proc Natl Acad Sci USA 2003; 100:7731–7736.PubMedCrossRefGoogle Scholar
  35. 35.
    Kuo CT, Veselits ML, Leiden JM. LKLF: A transcriptional regulator of single-positive T-cell quiescence and survival. Science 1997; 277:1986–1990.PubMedCrossRefGoogle Scholar
  36. 36.
    Schober SL, Kuo CT, Schluns KS et al. Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T-cells in vitro and in vivo. J Immunol 1999; 163:3662–3667.PubMedGoogle Scholar
  37. 37.
    Buckley AF, Kuo CT, Leiden JM. Transcription factor LKLF is sufficient to program T-cell quiescence via a c-Myc-dependent pathway. Nat Immunol 2001; 2:698–704.PubMedCrossRefGoogle Scholar
  38. 38.
    Bai A, Hu H, Yeung M et al. Kruppel-like factor 2 controls T-cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J Immunol 2007; 178:7632–7639.PubMedGoogle Scholar
  39. 39.
    Nutt SL, Kallies A, Belz GT. Blimp-1 connects the intrinsic and extrinsic regulation of T-cell homeostasis. J Clin Immunol 2008; 28:97–106.PubMedCrossRefGoogle Scholar
  40. 40.
    Martins G, Calame K. Regulation and functions of blimp-1 in T-and B-lymphocytes. Annu Rev Immunol 2008; 26:133–169.PubMedCrossRefGoogle Scholar
  41. 41.
    Martins GA, Cimmino L, Shapiro-Shelef M et al. Transcriptional repressor Blimp-1 regulates T-cell homeostasis and function. Nat Immunol 2006; 7:457–465.PubMedCrossRefGoogle Scholar
  42. 42.
    Dent AL, Shaffer AL, Yu X et al. Control of inflammation, cytokine expression and germinal center formation by BCL-6. Science 1997; 276:589–592.PubMedCrossRefGoogle Scholar
  43. 43.
    Ichii H, Sakamoto A, Hatano M et al. Role for Bcl-6 in the generation and maintenance of memory CD8+ T-cells. Nat Immunol 2002; 3:558–563.PubMedCrossRefGoogle Scholar
  44. 44.
    Yoshida K, Sakamoto A, Yamashita K et al. Bcl6 controls granzyme B expression in effector CD8+ T-cells. Eur J Immunol 2006; 36:3146–3156.PubMedCrossRefGoogle Scholar
  45. 45.
    Lemercier C, Brocard MP, Puvion-Dutilleul F et al. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J Biol Chem 2002; 277:22045–22052.PubMedCrossRefGoogle Scholar
  46. 46.
    Ichii H, Sakamoto A, Kuroda Y et al. Bcl6 acts as an amplifier for the generation and proliferative capacity of central memory CD8+ T-cells. J Immunol 2004; 173:883–891.PubMedGoogle Scholar
  47. 47.
    Manders PM, Hunter PJ, Telaranta AI et al. BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T-lymphocytes. Proc Natl Acad Sci USA 2005; 102:7418–7425.PubMedCrossRefGoogle Scholar
  48. 48.
    Okabe S, Fukuda T, Ishibashi K et al. BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor. Mol Cell Biol 1998; 18:4235–4244.PubMedGoogle Scholar
  49. 49.
    Takenaga M, Hatano M, Takamori M et al. Bcl6-dependent transcriptional repression by BAZF. Biochem Biophys Res Commun 2003; 303:600–608.PubMedCrossRefGoogle Scholar
  50. 50.
    Murre C. Helix-loop-helix proteins and lymphocyte development. Nat Immunol 2005; 6:1079–1086.PubMedCrossRefGoogle Scholar
  51. 51.
    Cannarile MA, Lind NA, Rivera R et al. Transcriptional regulator Id2 mediates CD8(+) T-cell immunity. Nat Immunol 2006 Dec;7(12):1317–25.PubMedCrossRefGoogle Scholar
  52. 52.
    Barthel R, Tsytsykova AV, Barczak AK et al. Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol Cell Biol 2003; 23:526–533.PubMedCrossRefGoogle Scholar
  53. 53.
    Monteiro M, Evaristo C, Legrand A et al. Cartography of gene expression in CD8 single cells: novel CCR7-subsets suggest differentiation independent of CD45RA expression. Blood 2007; 109:2863–2870.PubMedGoogle Scholar
  54. 54.
    Kim SJ, Glick A, Sporn MB et al. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem 1989; 264:402–408.PubMedGoogle Scholar
  55. 55.
    Kim SJ, Angel P, Lafyatis R et al. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 1990; 10:1492–1497.PubMedGoogle Scholar
  56. 56.
    Geiser AG, Kim SJ, Roberts AB et al. Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol 1991; 11:84–92.PubMedGoogle Scholar
  57. 57.
    Ventura JJ, Kennedy NJ, Flavell RA et al. JNK regulates autocrine expression of TGF-beta1. Mol Cell 2004; 15:269–278.PubMedCrossRefGoogle Scholar
  58. 58.
    Tsai EY, Jain J, Pesavento PA et al. Tumor necrosis factor alpha gene regulation in activated T-cells involves ATF-2/Jun and NFATp. Mol Cell Biol 1996; 16:459–467.PubMedGoogle Scholar
  59. 59.
    Baena A, Mootnick AR, Falvo JV et al. Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity. PLoS ONE 2007; 2:e621.PubMedCrossRefGoogle Scholar
  60. 60.
    Jain J, Loh C, Rao A. Transcriptional regulation of the IL-2 gene. Curr Opin Immunol 1995; 7:333–342.PubMedCrossRefGoogle Scholar
  61. 61.
    Hwang ES, Hong JH, Glimcher LH. IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J Exp Med 2005; 202:1289–1300.PubMedCrossRefGoogle Scholar
  62. 62.
    Thomas RM, Chunder N, Chen C et al. Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T-lymphocytes. J Immunol 2007; 179:7305–7315.PubMedGoogle Scholar
  63. 63.
    Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007; 96:41–101.PubMedCrossRefGoogle Scholar
  64. 64.
    Glimcher LH, Townsend MJ, Sullivan BM et al. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol 2004; 4:900–911.PubMedCrossRefGoogle Scholar
  65. 65.
    Moriuchi H, Moriuchi M, Fauci AS. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 1997; 158:3483–3491.PubMedGoogle Scholar
  66. 66.
    Song A, Chen YF, Thamatrakoln K et al. RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T-lymphocytes. Immunity 1999; 10:93–103.PubMedCrossRefGoogle Scholar
  67. 67.
    Szabo SJ et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100:655–669.PubMedCrossRefGoogle Scholar
  68. 68.
    Kaech SM, Hemby S, Kersh E et al. Molecular and functional profiling of memory CD8 T-cell differentiation. Cell 2002; 111:837–851.PubMedCrossRefGoogle Scholar
  69. 69.
    Peixoto A, Monteiro M, Rocha B et al. Q uantification of multiple gene expression in individual cells. Genome Res 2004; 14:1938–1947.PubMedCrossRefGoogle Scholar
  70. 70.
    Wherry EJ, Ha SJ, Kaech SM et al. Molecular Signature of CD8(+) T-Cell Exhaustion during Chronic Viral Infection. Immunity 2007; 27:670–684.PubMedCrossRefGoogle Scholar
  71. 71.
    Diehn M, Alizadeh AA, Rando OJ et al. Genomic expression programs and the integration of the CD28 costimulatory signal in T-cell activation. Proc Natl Acad Sci USA 2002; 99:11796–11801.PubMedCrossRefGoogle Scholar
  72. 72.
    Guillaume S, Tuosto L, Tanchot C et al. Proximal changes in signal transduction that modify CD8+ T-cell responsiveness in vivo. Eur J Immunol 2003; 33:2551–2556.PubMedCrossRefGoogle Scholar
  73. 73.
    D’Souza WN, Lefrancois L. Frontline: An in-depth evaluation of the production of IL-2 by antigen-specific CD8 T-cells in vivo. Eur J Immunol 2004; 34:2977–2985.PubMedCrossRefGoogle Scholar
  74. 74.
    Williams MA, Tyznik AJ, Bevan MJ. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T-cells. Nature 2006; 441:890–893.PubMedCrossRefGoogle Scholar
  75. 75.
    Grayson JM, Harrington LE, Lanier JG et al. Differential sensitivity of naive and memory CD8+ T-cells to apoptosis in vivo. J Immunol 2002; 169:3760–3770.PubMedGoogle Scholar
  76. 76.
    Jabbari A, Harty JT. Secondary memory CD8+ T-cells are more protective but slower to acquire a central-memory phenotype. J Exp Med 2006; 203:919–932.PubMedCrossRefGoogle Scholar
  77. 77.
    Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3:133–146.PubMedCrossRefGoogle Scholar
  78. 78.
    Cousens LP, Peterson R, Hsu S et al. Two roads diverged: interferon alpha/beta-and interleukin 12-mediated pathways in promoting T-cell interferon gamma responses during viral infection. J Exp Med 1999; 189:1315–1328.PubMedCrossRefGoogle Scholar
  79. 79.
    Way SS, Havenar-Daughton C, Kolumam GA et al. IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T-cells, whereas neither are required for IFN-gamma production by CD8 T-cells after Listeria monocytogenes infection. J Immunol 2007; 178:4498–4505.PubMedGoogle Scholar
  80. 80.
    Thomas DA, Massague J. TGF-beta directly targets cytotoxic T-cell functions during tumor evasion of immune surveillance. Cancer Cell 2005; 8:369–380.PubMedCrossRefGoogle Scholar
  81. 81.
    Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008; 28:468–476.PubMedCrossRefGoogle Scholar
  82. 82.
    Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T-cell subsets: function, generation and maintenance. Annu Rev Immunol 2004; 22:745–763.PubMedCrossRefGoogle Scholar
  83. 83.
    Appay V, Dunbar PR, Callan M et al. Memory CD8+ T-cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379–385.PubMedCrossRefGoogle Scholar
  84. 84.
    Rufer N, Zippelius A, Batard P et al. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood 2003; 102:1779–1787.PubMedCrossRefGoogle Scholar
  85. 85.
    Romero P et al. Four functionally distinct populations of human effector-memory CD8+ T-lymphocytes. J Immunol 2007; 178:4112–4119.PubMedGoogle Scholar
  86. 86.
    Swanson BJ, Murakami M, Mitchell TC et al. RANTES production by memory phenotype T-cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 2002; 17:605–615.PubMedCrossRefGoogle Scholar
  87. 87.
    Marçais A, Tomkowiak M, Walzer T et al. Maintenance of CCL5 mRNA stores by post-effector and memory CD8 T-cells is dependent on transcription and is coupled to increased mRNA stability. Eur J Immunol 2006; 36:2745–2754.PubMedCrossRefGoogle Scholar
  88. 88.
    Catalfamo M, Karpova T, McNally J et al. Human CD8+ T-cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 2004; 20:219–230.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  • Ivana Munitic
    • 1
  • César Evaristo
    • 1
  • Hsueh Cheng Sung
    • 1
  • Benedita Rocha
    • 1
  1. 1.Faculté de Médecine René Descartes Paris 5INSERM, U591ParisFrance

Personalised recommendations